Shine secures $50M in financing

2016 09 13 17 07 43 134 Atomic Technology 400

Medical isotope firm Shine Medical Technologies has secured $50 million in financing with funds managed by Oaktree Capital Management of Los Angeles.

The funds will support Shine's ongoing construction of a new production facility and its commercialization of the diagnostic and therapeutic isotopes molybdenum-99 (Mo-99) and lutetium-177 (Lu-177).

Shine expects construction of the new facility to be completed in 2021 and isotope production to begin in 2022, the company said.

Page 1 of 435
Next Page